The first needle-free epinephrine nasal spray, Neffy by ARS Pharmaceuticals, represents a significant breakthrough in ...
Study exceeded target enrollment, with an expected topline data readout from the interim analysis expected in 2025 - ...
Quality issues were found in several generic drugs by regulatory agencies in Tamil Nadu and Maharashtra. Alerts have been ...
Liposomal Doxorubicin Market Liposomal Doxorubicin Market Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Liposomal ...
SIFI, a leading international ophthalmic company, announced that is has received a Notice of Allowance from the European Patent Office ('EPO') for EP4216966. The newly granted patent, entitled 'formul ...
Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...
Swissmedic is expected to decide on the approval of the first new drug for Alzheimer’s disease in two decades. The decision ...